Gromwell (Lithospermum erythrorhizon) supplementation enhances epidermal levels of ceramides, glucosylceramides, β-glucocerebrosidase, and acidic sphingomyelinase in NC/Nga Mice

Journal of Medicinal Food

Volumn 16, Issue 10, 2013, Pages 927-933

  Kim, Jungmin ^a   Cho, Yunhi ^a  

^a Kyung Hee University   (South Korea)

Author keywords

acidic sphingomyelinase; b glucocerebrosidase; ceramides; glucosylceramides; gromwell; Lithospermum erythrorhizon; NC Nga mice

Indexed keywords

BETA GLUCOSYLCERAMIDASE; CERAMIDE; DERMATOLOGICAL AGENT; GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDE; LITHOSPERMIC ACID; LITHOSPERMUM ERYTHRORHIZON EXTRACT; LITHOSPERMUM EXTRACT; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; EPIDERMIS; IN VITRO STUDY; LITHOSPERMUM; LITHOSPERMUM ERYTHRORHIZON; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THIN LAYER CHROMATOGRAPHY; WESTERN BLOTTING;

ANIMALS; CERAMIDES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; EPIDERMIS; GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDES; HUMANS; MALE; MICE; MICE, INBRED BALB C; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 84885978036     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2734     Document Type: Article

References (34)

1. Bown D: Encyclopedia of Herbs and Their Uses. Dorling Kindersley, London, 1995.
2. Fujita N, Sakaguchi I, Kobayashi H, et al.: An extract of the root of Lithospermum erythrorhizon accelerates wound healing in diabetic mice. Biol Pharm Bull 2003;26:329-335.
3. Cho MH, Paik YS, Hahn TR: Physical stability of shikonin derivatives from the roots of Lithospermum erythrorhizon cultivated in Korea. J Agric Food Chem 1999;47:4117-4120.
4. Yamamoto H, Zhao P, Yazaki K, Inoue K: Regulation of lithospermic acid B and shikonin production in Lithospermum erythrorhizon cell suspension cultures. Chem Pharm Bull 2002;50:1086-1090.
5. Konno C, Mizuno T, Hikino H: Isolation and hypoglycemic activity of lithospermans A, B, and C, glycans of Lithospermum erythrorhizon roots. Planta Med 1985;2:157-158.
6. Ishida T, Sakaguchi I: Protection of human keratinocytes from UVB-induced inflammation using root extract of Lithospermum erythrorhizon. Biol Pharm Bull 2007;30:928-934.
7. Chang MJ, Huang HC, Chang HC, Chang TM: Cosmetic formulations containing Lithospermum erythrorhizon root extract show moisturizing effects on human skin. Arch Dermatol Res 2008;300:317-323.
8. Kim J, Kim H, Jeong DH, Kim SH, Park SK, Cho Y: Comparative effect of gromwell (Lithospermum erythrorhizon) extract and borage oil on reversing epidermal hyperproliferation in guinea pigs. Biosci Biotechnol Biochem 2006;70:2086-2095.
9. Kim J, Kim Y, Seo D, Kim S, Lee S, Cho Y: Oral supplementation of Lithospermum erythrorhizon prevents the development of atopic dermatitis with reducing ceramide degradation in the epidermis of NC/Nga mice. Phytother Res 2009;23:1250-1256.
10. Holleran WM, Takagi Y, Uchida Y: Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett 2006;580:5456-5466.
11. Hamanaka S, Hara M, Nishio H, et al.: Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J Invest Dermatol 2002;119:416-423.
12. Uchida Y, Hara M, Nishino H, Otsuka F, Suzuki A, Uchida Y: Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 2000;41:2071-2082.
13. Jensen JM, Förl M, Winoto-Morbach S, et al.: Acid and neutral sphingomyelinase, ceramide synthase, and acid ceramidase activities in cutaneous aging. Exp Dermatol 2005;14:609-618.
14. Kim H, Kim J, Park J, et al.: Water extract of gromwell (Lithospermum erythrorhizon) enhances migration of human keratinocytes and dermal fibroblasts with increased lipid synthesis in an in vitro wound scratch model. Skin Pharmacol Physiol 2012; 25:57-64.
15. Takagi Y, Nakagawa H, Yaginuma T, Takema Y, Imokawa G: An accumulation of glucosylceramide in the stratum corneum due to attenuated activity of beta-glucocerebrosidase is associated with the early phase of UVB-induced alteration in cutaneous barrier function. Arch Dermatol Res 2005;297:18-25.
16. Holleran WM, Takagi Y, Menon GK, et al.: Permeability barrier requirements regulate epidermal beta-glucocerebrosidase. J Lipid Res 1994;35:905-912.
17. Aioi A, Tonogaito H, Suto H, et al.: Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis. Br J Dermatol 2001;144:12-18.
18. Macheleidt O, Kaiser HW, Sandhoff K: Deficiency of epidermal protein-bound omega hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002;119:166-173.
19. Bouwstra JA, Gooris GS, Dubbelaar FE, Weerheim AM, Ijzerman AP, Ponec M: Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J Lipid Res 1998;39:186-196.
20. Holleran WM, Ginns EI, Menon GK, et al.: Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 1994;93:1756-1764.
21. Jensen JM, Schütze S, Förl M, Krönke M, Proksch E: Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 1999;104:1761-1770.
22. Schmuth M, Man MQ, Weber F, et al.: Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol 2000;115:459-466.
23. Jensen JM, Fölster-Holst R, Baranowsky A, et al.: Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004;122:1423-1431.
24. Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G: Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 2002;119:433-439.
25. Chujor CS, Feingold KR, Elias PM, Holleran WM: Glucosylceramide synthase activity in murine epidermis: quantitation, localization, regulation, and the requirement for barrier homeostasis. J Lipid Res 1998;39:277-285.
26. Murata Y, Ogata J, Higaki Y, et al.: Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 1996;106:1242-1249.
27. Reagan-Shaw S, Nihal M, Ahmad N: Dose translation from animal to human studies revisited. FASEB J 2007;22:659-661.
28. Cho HR, Cho Y, Kim J, et al.: The effect of gromwell (Lithospermum erythrorhizon) extract on the stratum corneum hydration and ceramides content in atopic dermatitis patients. Ann Dermatol (Seoul) 2008;20:56-66.
29. Sancheti S, Sancheti S, Seo SY: Ameliorative effects of 7-methylcoumarin and 7-methoxycoumarin against CCI4-induced hepatotoxicity in rats. Drug Chem Toxicol 2013;36:42-47.
30. Duan J, Sugawara T, Hirose M, et al.: Dietary sphingolipids improve skin barrier functions via the upregulation of ceramide synthases in the epidermis. Exp Dermatol 2012;21:448-452.
31. Miyanishi K, Shiono N, Shirai H, Dombo M, Kimata H: Reduction of transepidermal water loss by oral intake of glucosylceramides in patients with atopic eczema. Allergy 2005;60: 1454-1455.
32. Sugawara T, Tsuduki T, Yano S, et al.: Intestinal absorption of dietary maize glucosylceramide in lymphatic duct cannulated rats. J Lipid Res 2010;51:1761-1769.
33. Gwon SY, Ahn JY, Chung CH, Moon BK, Ha TY: Lithospermum erythrorhizon suppresses high-fat diet-induced obesity, and acetylshikonin, a main compound of Lithospermum erythrorhizon, inhibits adipocyte differentiation. J Agric Food Chem 2012;60: 9089-9096.
34. Thuong PT, Kang KW, Kim JK, et al.: Lithospermic acid derivatives from Lithospermum erythrorhizon increased expression of serine palmitoyltransferase in human HaCaT cells. Bioorg Med Chem Lett 2009;19:1815-1817.